Telmisartan belongs to a class of antihypertensive drugs called angiotensin receptor blockers (ARBs). This medication is used to treat hypertension (high blood pressure). It works by blocking the action of certain substances that tighten the blood vessels, letting the blood to flow more smoothly & the heart to pump more efficiently. Telmisartan is also used to decrease the chances of stroke, heart attack or death in persons 55 years of age or older who are at high risk for cardiovascular diseases. Telmisartan comes as a tablet form to take by mouth. Telmisartan drug may be used alone or in combination with other drugs such as hydrochlorothiazide and amlodipine. It is available in different tablet strengths.
List of Key Players
The key players profiled in this report include Abbott Laboratories, Aurobindo Pharma, Boehringer Ingelheim International GmbH, Cipla Inc., Glaxosmithkline Plc (GSK), Mylan N.V., Sanofi, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd. (Actavis Generics), and Zydus Cadila.
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/10658
Increase in prevalence of high blood pressure (hypertension), growth in geriatric population, surge in number of government initiatives for creating awareness about cardiovascular and blood pressure diseases are the major factors that boost the growth of the telmisartan market. In addition, marketing approvals for generic versions of telmisartan, and chronic disorders such as diabetes, further drives the growth of the market. Moreover, change in lifestyle, which in turn is expected to surge the demand for telmisartan in the global market. However, drug shortages are likely to restrain the growth of the telmisartan market. Conversely, surge in research related to telmisartan drug in emerging economies is expected to offer lucrative opportunities during the forecast period.
COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. This COVID-19 pandemic has affected telmisartan production and import & export of raw material and finished goods, owing to shutdowns in various COVID-19-affected countries. Temporary disruptions of inputs or production might stress some companies, particularly those with inadequate liquidity. Moreover, delayed shipments & production schedules create financial problems for companies with heavy debts. This, in turn, has limited the impact of COVID-19 on the market.
The global telmisartan market is segmented into indication, distribution channel, and region.
For Purchase inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/10658
According to distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to depict significant growth during the forecast period due to rise in number of hospital pharmacies globally and wide availability in hospital pharmacies. Moreover, online pharmacies segment is expected to exhibit the highest growth rate during the forecast period, owing to increase in awareness of online pharmacy and rise in number of internet users.
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.